| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 568.483 | 745.381 | 700.765 | 654.297 | 730.119 | 654.456 | 791.645 | 889.675 | 898.884 | 865.585 |
| Total Income - EUR | 568.485 | 745.383 | 700.784 | 654.298 | 730.741 | 654.988 | 791.649 | 890.203 | 898.811 | 866.315 |
| Total Expenses - EUR | 510.248 | 667.719 | 632.423 | 606.011 | 661.406 | 599.055 | 703.022 | 783.790 | 807.065 | 791.766 |
| Gross Profit/Loss - EUR | 58.236 | 77.665 | 68.361 | 48.287 | 69.335 | 55.933 | 88.627 | 106.413 | 91.747 | 74.549 |
| Net Profit/Loss - EUR | 48.913 | 63.198 | 57.169 | 41.699 | 61.921 | 49.873 | 81.171 | 98.542 | 79.571 | 63.145 |
| Employees | 9 | 10 | 10 | 11 | 9 | 7 | 8 | 7 | 7 | 7 |
Check the financial reports for the company - Fibrobet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 85.342 | 82.145 | 76.530 | 73.172 | 67.862 | 62.792 | 57.986 | 72.505 | 95.341 | 112.005 |
| Current Assets | 147.558 | 197.731 | 215.387 | 211.010 | 216.698 | 219.639 | 278.586 | 322.239 | 342.128 | 357.762 |
| Inventories | 104.581 | 113.469 | 136.800 | 148.162 | 133.495 | 143.352 | 177.710 | 220.626 | 221.478 | 225.867 |
| Receivables | 13.078 | 36.686 | 37.185 | 32.741 | 18.941 | 12.101 | 9.995 | 7.696 | 7.791 | 7.168 |
| Cash | 29.900 | 47.576 | 41.402 | 30.106 | 64.262 | 64.186 | 90.881 | 93.917 | 112.859 | 124.727 |
| Shareholders Funds | 182.461 | 212.624 | 239.003 | 252.565 | 254.139 | 252.406 | 292.869 | 344.293 | 387.661 | 434.436 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 50.439 | 67.355 | 52.913 | 31.617 | 30.420 | 30.025 | 43.703 | 50.451 | 49.808 | 35.331 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4752 - 4752" | |||||||||
| CAEN Financial Year |
4752
|
|||||||||
Comments - Fibrobet Srl